ArticlePloS one2026
Day-night variation and age-related differences in gadolinium-based contrast media enhancement in the brain: A T1 mapping study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The glymphatic system clears metabolic waste from the brain and can be probed using contrast-enhanced MRI. We investigated whether early-phase gadolinium-based contrast agent (GBCA) uptake varies with time of day and age. In this retrospective study, 447 patients who underwent brain MRI for suspected movement disorders received pre- and post-contrast T1 mapping a median of 5.9 minutes after GBCA injection. Scans were categorized as daytime (n = 307) or nighttime (n = 140). Regional ΔT1 values were measured in the cerebral and cerebellar cortices, white matter, basal ganglia perivascular spaces, and choroid plexus. Daytime cohorts showed significantly greater cortical enhancement than nighttime cohorts, particularly in the frontal, parietal, and temporal lobes, while no differences were observed in white matter, perivascular spaces, or choroid plexus. Increasing age was independently associated with stronger cortical enhancement across both day and night scans, with no significant interaction between age and time. These findings suggest that cortical GBCA retention is influenced by both circadian timing and aging, supporting early-phase T1 mapping as a practical approach to evaluate human glymphatic function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.